[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PL2029149T3 - Uprzywilejowane immunologicznie i modulacyjne komórki progenitorowe - Google Patents

Uprzywilejowane immunologicznie i modulacyjne komórki progenitorowe

Info

Publication number
PL2029149T3
PL2029149T3 PL07719706T PL07719706T PL2029149T3 PL 2029149 T3 PL2029149 T3 PL 2029149T3 PL 07719706 T PL07719706 T PL 07719706T PL 07719706 T PL07719706 T PL 07719706T PL 2029149 T3 PL2029149 T3 PL 2029149T3
Authority
PL
Poland
Prior art keywords
progenitor cells
immune privileged
modulatory progenitor
modulatory
privileged
Prior art date
Application number
PL07719706T
Other languages
English (en)
Inventor
John E. Davies
Jane Ennis
Alejandro Gomez-Artistizabal
Dolores Baksh
Original Assignee
John E. Davies
Jane Ennis
Alejandro Gomez-Artistizabal
Dolores Baksh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by John E. Davies, Jane Ennis, Alejandro Gomez-Artistizabal, Dolores Baksh filed Critical John E. Davies
Publication of PL2029149T3 publication Critical patent/PL2029149T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0665—Blood-borne mesenchymal stem cells, e.g. from umbilical cord blood

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Vascular Medicine (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL07719706T 2006-05-05 2007-05-04 Uprzywilejowane immunologicznie i modulacyjne komórki progenitorowe PL2029149T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74650006P 2006-05-05 2006-05-05
EP07719706.9A EP2029149B1 (en) 2006-05-05 2007-05-04 Immune privileged and modulatory progenitor cells
PCT/CA2007/000781 WO2007128115A1 (en) 2006-05-05 2007-05-04 Immune privileged and modulatory progenitor cells

Publications (1)

Publication Number Publication Date
PL2029149T3 true PL2029149T3 (pl) 2017-12-29

Family

ID=38667370

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07719706T PL2029149T3 (pl) 2006-05-05 2007-05-04 Uprzywilejowane immunologicznie i modulacyjne komórki progenitorowe

Country Status (12)

Country Link
US (3) US8277794B2 (pl)
EP (1) EP2029149B1 (pl)
JP (1) JP5431146B2 (pl)
KR (1) KR101507174B1 (pl)
AU (1) AU2007247725B2 (pl)
BR (1) BRPI0710339A2 (pl)
CA (2) CA2871219C (pl)
ES (1) ES2633939T3 (pl)
IL (1) IL195067A (pl)
PL (1) PL2029149T3 (pl)
PT (1) PT2029149T (pl)
WO (1) WO2007128115A1 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1594957E (pt) 2003-02-11 2010-11-30 John E Davies Células progenitoras da geleia de wharton do cordão umbilical humano
JP2009520466A (ja) 2005-12-22 2009-05-28 エニス，ジエーン 凍結臍帯組織由来の生存可能な細胞
WO2007128115A1 (en) 2006-05-05 2007-11-15 Univ Toronto Immune privileged and modulatory progenitor cells
KR20100137006A (ko) 2008-04-21 2010-12-29 티슈 리제너레이션 쎄라퓨틱스, 인코포레이티드 생물학적 또는 화학적 물질에 대한 예방 또는 치료를 위한 유전적으로 변형된 인간 탯줄 혈관주위 세포
ES2612469T3 (es) 2008-08-20 2017-05-17 Anthrogenesis Corporation Composición celular mejorada y métodos de elaboración de la misma
EP2633861B1 (en) 2008-08-22 2015-08-12 Anthrogenesis Corporation Methods and compositions for treatment of bone defects with placental cell populations
NZ602798A (en) 2010-04-08 2014-10-31 Anthrogenesis Corp Treatment of sarcoidosis using placental stem cells
AU2011352036A1 (en) 2010-12-31 2013-07-18 Anthrogenesis Corporation Enhancement of placental stem cell potency using modulatory RNA molecules
EP2714059B1 (en) 2011-06-01 2018-10-03 Celularity, Inc. Treatment of pain using placental stem cells
US10400211B1 (en) 2014-04-28 2019-09-03 Donnie Rudd Cell composition for tissue regeneration
US11285177B2 (en) 2018-01-03 2022-03-29 Globus Medical, Inc. Allografts containing viable cells and methods thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE902301A1 (en) 1989-12-22 1991-07-03 Cryo Cell Internat Identification Process And Related Method For Use In¹Preparing A Biological Sample
US5919702A (en) 1996-10-23 1999-07-06 Advanced Tissue Science, Inc. Production of cartilage tissue using cells isolated from Wharton's jelly
US7670628B2 (en) 1999-07-07 2010-03-02 Angioblast Systems, Inc. Mesenchymal precursor cell
US20050158289A1 (en) 1999-07-07 2005-07-21 Simmons Paul J. Mesenchymal precursor cell and use thereof in the repair of bone defects and fractures in mammals
AUPQ147799A0 (en) 1999-07-07 1999-07-29 Medvet Science Pty. Ltd. Mesenchymal precursor cell
AU2003901668A0 (en) 2003-03-28 2003-05-01 Medvet Science Pty. Ltd. Non-haemopoietic precursor cells
NZ517002A (en) 1999-08-05 2004-06-25 Mcl Llc Multipotent adult stem cells and methods for isolation
JP2004531256A (ja) 2001-04-24 2004-10-14 バクシュ，ドロレス 前駆細胞集団、その増殖、及びそれからの非造血細胞種及び組織の成長
US7736892B2 (en) 2002-02-25 2010-06-15 Kansas State University Research Foundation Cultures, products and methods using umbilical cord matrix cells
US20030161818A1 (en) 2002-02-25 2003-08-28 Kansas State University Research Foundation Cultures, products and methods using stem cells
PT1594957E (pt) 2003-02-11 2010-11-30 John E Davies Células progenitoras da geleia de wharton do cordão umbilical humano
KR20120035234A (ko) 2003-04-11 2012-04-13 메디뮨 엘엘씨 재조합 ｉｌ?９ 항체 및 그의 용도
CA2530422C (en) 2003-06-27 2016-01-05 Ian Ross Harris Postpartum-derived cells for use in treatment of disease of the heart and circulatory system
EP1639099B1 (en) 2003-06-27 2011-05-18 Université Laval Method of isolating cells from umbilical cord
CA2539274C (en) 2003-09-16 2016-03-15 21St Century Medicine, Inc. Methods and compositions for the cryopreservation of organs
DK1725656T3 (da) 2004-03-05 2014-01-13 John E Davies Serumfri suspensionskultursystem til mesenchymale progenitorceller
WO2006019357A1 (en) 2004-08-16 2006-02-23 Cellresearch Corporation Pte Ltd Isolation of stem/progenitor cells from amniotic membrane of umbilical cord.
JP2009520466A (ja) 2005-12-22 2009-05-28 エニス，ジエーン 凍結臍帯組織由来の生存可能な細胞
US20090280093A1 (en) 2006-03-01 2009-11-12 The Regenerative Medicine Institute Compositions and populations of cells obtained from the umbilical cord and methods of producing the same
WO2007128115A1 (en) 2006-05-05 2007-11-15 Univ Toronto Immune privileged and modulatory progenitor cells

Also Published As

Publication number Publication date
EP2029149B1 (en) 2017-04-19
US8900573B2 (en) 2014-12-02
AU2007247725A1 (en) 2007-11-15
EP2029149A1 (en) 2009-03-04
CA2871219A1 (en) 2007-11-15
CA2649874A1 (en) 2007-11-15
EP2029149A4 (en) 2012-03-28
CA2649874C (en) 2015-01-27
KR20090033328A (ko) 2009-04-02
ES2633939T3 (es) 2017-09-26
IL195067A (en) 2015-11-30
US20130089565A1 (en) 2013-04-11
US20090285842A1 (en) 2009-11-19
US8277794B2 (en) 2012-10-02
JP5431146B2 (ja) 2014-03-05
BRPI0710339A2 (pt) 2011-08-09
PT2029149T (pt) 2017-08-23
US20150246079A1 (en) 2015-09-03
KR101507174B1 (ko) 2015-04-01
JP2009536163A (ja) 2009-10-08
AU2007247725B2 (en) 2013-02-14
IL195067A0 (en) 2009-08-03
WO2007128115A1 (en) 2007-11-15
CA2871219C (en) 2020-06-30

Similar Documents

Publication Publication Date Title
IL195067A0 (en) Immune privileged and modulatory progenitor cells
HUS1800024I1 (hu) Glicerinhez kapcsolódó pegilált cukrok és glükopeptidek
IL213365A (en) Imidazopyrazine and their pharmaceutical preparations
EP2057708A4 (en) INTEGRATED SOLID OXIDE FUEL CELL AND FUEL PROCESSOR
IL225740A0 (en) Adapted factor vii polypeptides and uses thereof
IL221278A0 (en) Chlorotoxin polypeptides and conjugates and uses thereof
EP2318029A4 (en) MODIFIED BOVINE G-CSF POLYPEPTIDES AND USES THEREOF
IL198892A0 (en) Endodermal progenitor cells
GB0712670D0 (en) Isolated peptides and uses thereof
PL2201818T3 (pl) Elektryczny element łączący i szyba zaopatrzona w tego rodzaju element
EP2057707A4 (en) INTEGRATED SOLID OXIDE FUEL CELL AND FUEL PROCESSOR
GB0720092D0 (en) Improvements in bus stops and bus shelters
EP2146728A4 (en) PROGENITOR CELLS FROM URINE AND METHODS FOR THEIR USE
TWI372866B (en) Peptides specific for hepatocellular carcinoma cells and applications thereof
ZA201101853B (en) Fuel compositions comprising limonane and farnesane
ZA201104160B (en) Crhr2 peptide agonists and uses thereof
ZA200807832B (en) Maduramicin compositions and methods
GB0800701D0 (en) F10 Polypeptides and uses thereof
GB0710813D0 (en) Peptides and uses thereof
HK1098297A2 (en) Anti-shaking and inner-lock screwed junction structure
AU2008902600A0 (en) Polypeptides and uses thereof
AU2007905623A0 (en) Improvement in the Distribution and Utilisation of Methanol
GB0816561D0 (en) Peptides and uses thereof
GB0820492D0 (en) Cell compositions and uses thereof
GB0612873D0 (en) Isolated peptides and uses thereof